The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence

被引:82
作者
Bruijnzeel, AW
Gold, MS
机构
[1] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA
[3] Univ Florida, Dept Anesthesiol, Gainesville, FL 32610 USA
[4] Univ Florida, Dept Community Hlth, Gainesville, FL 32610 USA
[5] Univ Florida, Dept Family Med, Gainesville, FL 32610 USA
[6] Univ Florida, Div Addict Med, Gainesville, FL 32610 USA
关键词
drug dependence; stress; comorbidity; nicotine; cannabis; alcohol;
D O I
10.1016/j.brainresrev.2005.01.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The corticotropin-releasing factor (CRF)-like peptides, which include the mammalian peptides CRF, urocortin 1, urocortin 2, and urocortin 3, play an important role in orchestrating behavioral and physiological responses that may increase an organism's chance of survival when confronted with internal or external stressors. There is, however, evidence that a chronic overactivity of brain CRF systems under basal conditions may play a role in the etiology and maintenance of psychiatric disorders such as depression and anxiety disorders. In addition, there is evidence of a role for CRF-like peptides in acute and protracted drug abstinence syndromes and relapse to drug-taking behavior. This review focuses on the role of CRF-like peptides in the negative affective state associated with acute and protracted withdrawal from three widely abused drugs, cannabis, nicotine, and alcohol. In addition, we discuss the high comorbidity between stress-associated psychiatric disorders and drug dependence. A better understanding of the brain stress systems that may underlie psychiatric disorders, acute and protracted drug withdrawal, and relapse to drug-taking behavior may help in the development of new and improved pharmacotherapies for these widespread psychiatric disorders. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:505 / 528
页数:24
相关论文
共 338 条
[31]   DEPRESSIVE AFFECT AND ENDOCRINE FUNCTIONS - BLOOD LEVELS OF ADRENAL CORTEX AND THYROID HORMONES IN PATIENTS SUFFERING FROM DEPRESSIVE REACTIONS [J].
BOARD, F ;
WADESON, R ;
PERSKY, H .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1957, 78 (DEC) :612-620
[32]   Dose-related neurocognitive effects of marijuana use [J].
Bolla, KI ;
Brown, K ;
Eldreth, D ;
Tate, K ;
Cadet, JL .
NEUROLOGY, 2002, 59 (09) :1337-1343
[33]   Stress Sensitization of ethanol withdrawal-induced reduction in social interaction:: Inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist [J].
Breese, GR ;
Knapp, DJ ;
Overstreet, DH .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (03) :470-482
[34]  
Bremner JD, 1997, AM J PSYCHIAT, V154, P624
[35]  
BROWN WA, 1979, AM J PSYCHIAT, V136, P230
[36]  
BROWN WA, 1980, ARCH GEN PSYCHIAT, V37, P747
[37]   Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats [J].
Bruijnzeel, AW ;
Markou, A .
NEUROPHARMACOLOGY, 2004, 47 (04) :572-579
[38]   Stress-induced sensitization of CRH-ir but not P-CREB-ir responsivity in the rat central nervous system [J].
Bruijnzeel, AW ;
Stam, R ;
Compaan, JC ;
Wiegant, VM .
BRAIN RESEARCH, 2001, 908 (02) :187-196
[39]   Stress reinstates nicotine seeking but not sucrose solution seeking in rats [J].
Buczek, Y ;
Lê, AD ;
Wang, A ;
Stewart, J ;
Shaham, Y .
PSYCHOPHARMACOLOGY, 1999, 144 (02) :183-188
[40]   The time course and significance of cannabis withdrawal [J].
Budney, AJ ;
Moore, BA ;
Vandrey, RG ;
Hughes, JR .
JOURNAL OF ABNORMAL PSYCHOLOGY, 2003, 112 (03) :393-402